XML 18 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Changes In Stockholders' Equity - USD ($)
$ in Thousands
Total
Adjustment to apply recent accounting pronouncements
Common Stock
Preferred Stock
Additional Paid-in Capital
Retained Earnings
Retained Earnings
Adjustment to apply recent accounting pronouncements
Accumulated Other Comprehensive Income (Loss)
Treasury Stock
Beginning balance (in shares) at Dec. 31, 2018     106,375,000            
Beginning balance at Dec. 31, 2018 $ 2,054,998 $ 47,257 [1] $ 1,157 $ 0 $ 1,114,580 $ 1,192,767 $ 47,257 [1] $ (52,512) $ (200,994)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 147,617         147,617      
Other comprehensive income (loss) 59,250             59,250  
Common dividends declared (43,746)         (43,746)      
Repurchases of common stock (in shares)     (1,687,000)            
Repurchases of common stock (33,928)               (33,928)
Acquisitions, net of issuance costs (in shares)     4,879,000            
Acquisition, net of issuance costs 101,496   $ 47   97,351       4,098
Common stock issued (in shares)     34,000            
Common stock issued 687       12       675
Restricted stock activity (in shares)     380,000            
Restricted stock activity (3,833)       (13,919)       10,086
Treasury stock issued to benefit plans (in shares)     (11,000)            
Treasury stock issued to benefit plans (217)       (12)       (205)
Share-based compensation expense 10,018       10,018        
Ending balance (in shares) at Sep. 30, 2019     109,970,000            
Ending balance at Sep. 30, 2019 2,339,599   $ 1,204 0 1,208,030 1,343,895   6,738 (220,268)
Beginning balance (in shares) at Jun. 30, 2019     110,589,000            
Beginning balance at Jun. 30, 2019 2,300,573   $ 1,204 0 1,205,396 1,304,756   (2,810) (207,973)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 54,545         54,545      
Other comprehensive income (loss) 9,548             9,548  
Common dividends declared (15,406)         (15,406)      
Repurchases of common stock (in shares)     (645,000)            
Repurchases of common stock (12,738)               (12,738)
Common stock issued (in shares)     4,000            
Common stock issued 82       81       1
Restricted stock activity (in shares)     27,000            
Restricted stock activity (63)       (599)       536
Treasury stock issued to benefit plans (in shares)     (5,000)            
Treasury stock issued to benefit plans (97)       (3)       (94)
Share-based compensation expense 3,155       3,155        
Ending balance (in shares) at Sep. 30, 2019     109,970,000            
Ending balance at Sep. 30, 2019 $ 2,339,599   $ 1,204 0 1,208,030 1,343,895   6,738 (220,268)
Beginning balance (in shares) at Dec. 31, 2019 109,972,000   109,972,000            
Beginning balance at Dec. 31, 2019 $ 2,370,793 $ (26,821) [2] $ 1,204 0 1,211,274 1,380,612 $ (26,821) [2] (1,954) (220,343)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 66,293         66,293      
Other comprehensive income (loss) 27,703             27,703  
Preferred dividends (5,070)         (5,070)      
Common dividends declared (48,028)         (48,028)      
Repurchases of common stock (in shares)     (1,171,000)            
Repurchases of common stock (22,557)               (22,557)
Acquisitions, net of issuance costs (in shares)     4,930,000            
Acquisition, net of issuance costs 71,883   $ 49   71,834        
Preferred stock issued 221,047     230,500 (9,453)        
Common stock issued (in shares)     49,000            
Common stock issued 1,007   $ 1   327       679
Restricted stock activity (in shares)     531,000            
Restricted stock activity (3,063)       (13,311)       10,248
Treasury stock issued to benefit plans (258)       (54)       (204)
Share-based compensation expense (in shares)     (18,000)            
Share-based compensation expense $ 11,242       11,242        
Ending balance (in shares) at Sep. 30, 2020 114,293,000   114,293,000            
Ending balance at Sep. 30, 2020 $ 2,664,171   $ 1,254 230,500 1,271,859 1,366,986   25,749 (232,177)
Beginning balance (in shares) at Jun. 30, 2020     114,276,000            
Beginning balance at Jun. 30, 2020 2,656,211   $ 1,253 230,500 1,268,647 1,359,407   28,727 (232,323)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                  
Net income 27,623         27,623      
Other comprehensive income (loss) (2,978)             (2,978)  
Preferred dividends (4,033)         (4,033)      
Common dividends declared (16,011)         (16,011)      
Preferred stock issued (265)       (265)        
Common stock issued (in shares)     6,000            
Common stock issued 77   $ 1   76       0
Restricted stock activity (in shares)     18,000            
Restricted stock activity 72       (131)       203
Treasury stock issued to benefit plans (in shares)     11,000            
Treasury stock issued to benefit plans (90)       (33)       (57)
Share-based compensation expense (in shares)     (18,000)            
Share-based compensation expense $ 3,565       3,565        
Ending balance (in shares) at Sep. 30, 2020 114,293,000   114,293,000            
Ending balance at Sep. 30, 2020 $ 2,664,171   $ 1,254 $ 230,500 $ 1,271,859 $ 1,366,986   $ 25,749 $ (232,177)
[1] As a result of accounting guidance adopted in the first quarter of 2019, the remaining deferred gain on a sale-leaseback transaction was recognized as a cumulative-effect adjustment to retained earnings as of January 1, 2019.
[2] As a result of accounting guidance adopted in the first quarter of 2020, a portion of the increase in allowance for credit losses, net of tax, was recognized as a cumulative-effect adjustment to retained earnings as of January 1, 2020. For further discussion of this guidance, see Note 2, "Recent Accounting Pronouncements and Other Guidance."